
(S,R,S)-AHPC-PEG2-NH2 hydrochloride NEW
Price | $33 | $68 | $107 |
Package | 10mg | 25mg | 50mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-07-10 |
Product Details
Product Name: (S,R,S)-AHPC-PEG2-NH2 hydrochloride | CAS No.: 2097973-72-1 |
Purity: 99.29% | Supply Ability: 10g |
Release date: 2025/07/10 |
Product Introduction
Bioactivity
Name | (S,R,S)-AHPC-PEG2-NH2 hydrochloride |
Description | (S,R,S)-AHPC-PEG2-NH2 hydrochloride (E3 ligase Ligand-Linker Conjugates 6) is a synthesized E3 ligase ligand-linker conjugate that includes the (S,R,S)-AHPC based VHL ligand and a 2-unit PEG linker used in the synthesis of PROTAC. |
In vitro | PROTACs consist of two ligands joined by a linker: one targets an E3 ubiquitin ligase, and the other targets the desired protein. They harness the intracellular ubiquitin-proteasome system to selectively degrade these target proteins[1]. |
Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Solubility Information | DMSO : 100 mg/mL (163.35 mM), Sonication is recommended. H2O : 100 mg/mL (163.35 mM), Sonication is recommended. |
Keywords | VHL Ligand-Linker Conjugates 3 Hydrochloride | VHL Ligand-Linker Conjugates 3 | VHL | VH032-PEG2-NH2 Hydrochloride | Inhibitor | inhibit | E3LigaseLigandLinkerConjugate | E3 Ligase Ligand-Linker Conjugates | E3 Ligase Ligand-Linker Conjugate | E3 Ligase LigandLinker Conjugate | AHPC-PEG2-NH2 Hydrochloride | (S,R,S)-AHPC-PEG-2-NH2 hydrochloride | (S,R,S)AHPCPEG2NH2 hydrochloride | (S,R,S) AHPC PEG2 NH2 hydrochloride |
Inhibitors Related | Thalidomide-O-amido-PEG2-C2-NH2 TFA | Thalidomide-O-amido-C3-NH2 TFA | Thalidomide-O-amido-C6-NH2 hydrochloride | Thalidomide-O-amido-PEG3-C2-NH2 TFA | Thalidomide 4'-ether-alkylC2-amine hydrochloride | (S,R,S)-AHPC-PEG3-N3 | Thalidomide-NH-C2-PEG3-OH | Thalidomide-NH-C4-NH-Boc | Pomalidomide 4'-PEG3-azide | Thalidomide-O-C6-NH2 hydrochloride | Thalidomide-O-amido-C4-NH2 TFA | Pomalidomide-C2-NH2 hydrochloride |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/100mg |
VIP2Y
|
Xian confluore Biological Technology Co., Ltd.
|
2024-04-01 | |
$31.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$0.00/25kg |
VIP1Y
|
Hovane Phytochemicals Co., Ltd
|
2024-11-07 | |
$0.00/100mg |
VIP2Y
|
Xian confluore Biological Technology Co., Ltd.
|
2024-04-01 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY